PA
PJP icon

Parallel Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Parallel Advisors’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16
Closed -$1.72K – 3932
2025
Q4 		$1.72K Hold
16
– – ﹤0.01% 3166
2025
Q3 		$1.52K Hold
16
– – ﹤0.01% 3121
2025
Q2 		$1.3K Hold
16
– – ﹤0.01% 3145
2025
Q1 		$1.41K Hold
16
– – ﹤0.01% 3058
2024
Q4 		$1.34K Hold
16
– – ﹤0.01% 3063
2024
Q3 		$1.41K Hold
16
– – ﹤0.01% 2965
2024
Q2 		$1.33K Hold
16
– – ﹤0.01% 2897
2024
Q1 		$1.29K Hold
16
– – ﹤0.01% 2894
2023
Q4 		$1.22K Hold
16
– – ﹤0.01% 2901
2023
Q3 		$1.16K Buy
+16
New +$1.23K ﹤0.01% 2950

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Parallel Advisors's PJP Position: Q1 2026 in Review

Parallel Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2026, closing a stake of 16 shares — an estimated $1.72K sold.

Parallel Advisors first reported a position in PJP in Q3 2023 and held it in 10 quarters. The position peaked at $1.72K in Q4 2025. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Parallel Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2026 after selling out during the quarter.
  • Parallel Advisors sold 16 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $1.72K.
  • Parallel Advisors first reported a position in Invesco Pharmaceuticals ETF in Q3 2023 and held it in 10 quarters.
  • Parallel Advisors's Invesco Pharmaceuticals ETF position peaked at $1.72K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.